Cargando…
Arenobufagin activates p53 to trigger esophageal squamous cell carcinoma cell apoptosis in vitro and in vivo
Esophageal squamous cell carcinoma (ESCC) is often diagnosed at late incurable stage and lacks effective treatment strategy. Bufadienolides are cardiotonic steroids isolated from the skin and parotid venom glands of the toad Bufo bufo gargarizans Cantor with novel anticancer activity. However, there...
Autores principales: | Lv, Junhong, Lin, Shaohuan, Peng, Panli, Cai, Changqing, Deng, Jianming, Wang, Mingzhi, Li, Xuejun, Lin, Rongsheng, Lin, Yu, Fang, Ailing, Li, Qiling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338965/ https://www.ncbi.nlm.nih.gov/pubmed/28280360 http://dx.doi.org/10.2147/OTT.S104767 |
Ejemplares similares
-
Bufadienolides induce p53-mediated apoptosis in esophageal squamous cell carcinoma cells in vitro and in vivo
por: Lin, Shaohuan, et al.
Publicado: (2018) -
Cytotoxic Effects of Hellebrigenin and Arenobufagin Against Human Breast Cancer Cells
por: Zhang, Yu, et al.
Publicado: (2021) -
Arenobufagin increases the sensitivity of gastric cancer to cisplatin via alkaliptosis
por: Liu, Chengwei, et al.
Publicado: (2023) -
Systemic delivery of the anticancer agent arenobufagin using polymeric nanomicelles
por: Yuan, Xue, et al.
Publicado: (2017) -
Arenobufagin causes ferroptosis in human gastric cancer cells by increasing rev-erbα expression
por: Chen, Ke, et al.
Publicado: (2022)